The Global Endoscopic Retrograde Cholangiopancreatography Devices Market is Growing with a CAGR of 5.9% in the Forecast Period of 2021 to 2028

The Global Endoscopic Retrograde Cholangiopancreatography Devices Market is growing with factors such as the rising prevalence of biliary and pancreatic diseases, growing healthcare infrastructure, rising collaborations among key market players, among others. A large number of products available in the market is also propelling the demand of the market.

Technological advancements have propelled the demand of the market. However, the side effects of the procedure and high cost may impact the demand of the market.

Global Endoscopic Retrograde Cholangiopancreatography Devices Market Scenario  

According to Data Bridge Market Research, the global endoscopic retrograde cholangiopancreatography devices in North America has the highest market share, followed by Europe and Asia-Pacific. The market leader is Olympus Corporation which accounts for an estimated market share of approximately 23.20% in the global market. The company has gained outstanding sales by providing novel technology-based devices.

  • In October 2020, Olympus Corporation announced that it had launched two ERCP stone management devices, StoneMasterV and VorticCatrchV endotherapy devices, which will increase efficiency in bile duct stone management and has helped the company to generate revenue further

Endoscopic Retrograde Cholangiopancreatography Devices Market Trends Impacting the Market

Now the question is which other regions Olympus Corporation, Boston Scientific Corporation, and STERIS are targeting? Data Bridge Market Research has forecasted a large growth in the North America endoscopic retrograde cholangiopancreatography devices market. The market leaders target the U.S. and Canada to be their next pocket revenue for 2021.

The market of endoscopic retrograde cholangiopancreatography devices is becoming more competitive with Olympus Corporation, Boston Scientific Corporation, and STERIS. These are the top dominating companies in the endoscopic retrograde cholangiopancreatography devices market and have launched novel products. The Data Bridge Market Research new reports highlight the major growth factors and opportunities in the global endoscopic retrograde cholangiopancreatography devices market.

For more analysis on the endoscopic retrograde cholangiopancreatography devices request for a briefing with our analysts https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=global-endoscopic-retrograde-cholangiopancreatography-devices-market

Endoscopic Retrograde Cholangiopancreatography Devices Market Developments

  • In January 2021, Boston Scientific Corporation announced that it has agreed to acquire Preventice Solutions, Inc. The acquisition will help the company to expand its portfolio
  • In October 2020, STERIS announced the acquisition of Key Surgical, which is a manufacturer of disposable surgical products. This acquisition has helped the company to expand its business in coming years

Scope of the Endoscopic Retrograde Cholangiopancreatography Devices Market

The global endoscopic retrograde cholangiopancreatography devices market is segmented into countries the U.S., Canada, Mexico, Germany, France, U.K., Hungary, Lithuania, Austria, Ireland, Norway, Poland, Italy, Spain, Russia, Turkey, Netherlands, Switzerland, Rest of Europe, Japan,  China, South Korea, India, Australia, Singapore,  Thailand, Malaysia, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, South Africa, Saudi Arabia, UAE, Egypt, Kuwait, Israel and Rest of Middle East and Africa.

All country-based analysis of the global endoscopic retrograde cholangiopancreatography devices market is further analyzed based on maximum granularity into further segmentation. On the basis of product type, the global endoscopic retrograde cholangiopancreatography devices market is segmented into endotherapy devices, endoscopes, imaging devices, and others. On the basis of modality, the global endoscopic retrograde cholangiopancreatography devices market is segmented into single-use, standalone, and handheld.

  • On the basis of procedure, the global endoscopic retrograde cholangiopancreatography devices market is segmented into biliary sphincterotomy, biliary stenting, biliary dilation, pancreatic duct stenting, and pancreatic sphincterotomy.On the basis of application, the global endoscopic retrograde cholangiopancreatography devices market is segmented into the bile duct, pancreas, gall bladder, liver, and others. On the basis of end user, the global endoscopic retrograde cholangiopancreatography devices market is segmented into hospitals, ambulatory surgical centers, diagnostic laboratories, and others. On the basis of facility type, the global endoscopic retrograde cholangiopancreatography devices market is segmented into large, medium, and small. On the basis of distribution channel, the global endoscopic retrograde cholangiopancreatography devices market is segmented into direct tenders, third party distribution, and retail sales.
  • To know more about the study, https://www.databridgemarketresearch.com/reports/global-endoscopic-retrograde-cholangiopancreatography-devices-market

Key Pointers Covered in Endoscopic Retrograde Cholangiopancreatography Devices Market Industry Trends and Forecast to 2028

  • Market Size
  • Top to Bottom Market Analysis
  • Recent Developments for Market Competitors
  • Recent Market Value for Different Countries
  • Market value and overview of stem cell manufacturing market
  • Company profiling of top eight players of stem cell manufacturing market

Key Market Competitors Covered in the Report

  • Olympus Corporation
  • Boston Scientific Corporation
  • Medtronic
  • BD
  • Ambu Inc.
  • CONMED Corporation
  • HOBBS MEDICAL INC.
  • FUJIFILM Corporation
  • TeleMed Systems, Inc.
  • Merit Medical Systems
  • Cook
  • KARL STORZ SE & Co. KG
  • Johnson & Johnson Services, Inc.
  • HOYA Corporation
  • Medi-Globe GmbH
  •  STERIS
  • Shaili Endoscopy
  • Hospiline Equipments

 Above are the key players covered in the report, to know about more and exhaustive list of endoscopic retrograde cholangiopancreatography devices companies’ contact us https://www.databridgemarketresearch.com/toc/?dbmr=global-endoscopic-retrograde-cholangiopancreatography-devices-market

Research Methodology: Global Endoscopic Retrograde Cholangiopancreatography Devices Market

Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or can drop down your inquiry.

The key research methodology used by the DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include vendor positioning grid, market timeline analysis, market overview and guide, company positioning grid, company market share analysis, standards of measurement, top to bottom analysis, and vendor share analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents

  • Demand Side: Manufacturer, Geneticists, Healthcare Industry, Scientists, Research Laboratories
  • Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers, among others.

Related Reports

Browse in Healthcare Category Related Reports@ https://www.databridgemarketresearch.com/report-category/healthcare/